Thymosin alpha 1 as an adjuvant to hyperthermic intraperitoneal chemotherapy in an experimental model of peritoneal metastases from colonic carcinoma

医学 温热腹腔化疗 丝裂霉素C 佐剂 胃肠病学 CD8型 免疫系统 腹腔注射 内科学 化疗 免疫学 癌症 外科 细胞减少术 卵巢癌
作者
Nadav Nevo,Adam Lee Goldstein,Shoshi Bar-David,Maya Natanson,Gilad Alon,Guy Lahat,Eran Nizri‏
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:111: 109166-109166 被引量:9
标识
DOI:10.1016/j.intimp.2022.109166
摘要

Heated intraperitoneal chemotherapy (HIPEC) is currently implemented in the treatment of peritoneal metastases from colorectal carcinoma (PM-CRC) origin. However, recurrence is common and the effectiveness of HIPEC has been questioned. The aim of this study was to evaluate the use of thymosin alpha 1 (Tα1), an immunomodulatory molecule, as an adjuvant to HIPEC treatment.We developed an experimental model of HIPEC by the induction of PM-CRC in C57BL mice and intra-abdominal perfusion of mitomycin C (MMC). Mice were treated with Tα1 at 0.6 mg/kg for 5 days after HIPEC. Clinical and immunological parameters were compared between HIPEC and HIPEC + Tα1 groups.Treatment with Tα1 increased overall survival of mice compared to HIPEC treatment alone and sham-treated animals (16.1 ± 0.8 vs. 14.1 ± 0.6 and 11.8 ± 0.8, respectively, p = 0.02). Tα1 had no direct anti-tumor effect, as seen by lack of inhibition of tumor cell proliferation. Tα1 treatment induced a T helper (Th) 1 immune response in tumor metastases as evidenced by a significant increase of the Th1-specific markers IFN-γ and T-bet (1.21 ± 0.3 vs. 0.52 ± 0.08, p < 0.05; 0.88 ± 0.04 vs. 0.64 ± 0.14, p < 0.05, respectively). This Th1 skew was accompanied by increased CD8+ infiltration into omental and visceral metastases by Tα1 treatment compared to sham and HIPEC-treated animals (21.24 ± 2.16 vs. 10.45 ± 0.89 and 7.7 ± 1.3, p < 0.001; 14.12 ± 1.54 vs. 12.12 ± 0.01 and 6.64 ± 0.87, p < 0.01, respectively).Tα1 augments the effect of HIPEC by the induction of a Th1 anti-tumor immune response. Further experiments should evaluate Tα1 and other novel immunomodulators in order to exploit the immunological opportunities created by HIPEC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
可A完成签到,获得积分10
1秒前
moly完成签到,获得积分10
1秒前
奥利给完成签到,获得积分10
1秒前
1秒前
1秒前
Hello的应助被袁气奶豆采纳,获得10
1秒前
1秒前
云云纵声完成签到,获得积分10
1秒前
Ting330完成签到,获得积分20
2秒前
ding的应助被lfl采纳,获得10
2秒前
2秒前
2秒前
2秒前
星辰大海的应助被strack采纳,获得10
2秒前
竹林萤火完成签到 ,获得积分10
2秒前
3秒前
田様的应助被追寻谷兰采纳,获得10
3秒前
3秒前
3秒前
李爱国的应助被粥粥爱糊糊采纳,获得10
3秒前
624794951发布了新的文献求助10
3秒前
斯文幻天完成签到,获得积分10
3秒前
lc完成签到,获得积分10
4秒前
走四方完成签到,获得积分10
4秒前
4秒前
芊芊芊儿完成签到,获得积分10
5秒前
5秒前
yi_i发布了新的文献求助10
5秒前
6秒前
jjjj完成签到,获得积分10
6秒前
明理采文发布了新的文献求助10
6秒前
大模型的应助被Willing采纳,获得10
6秒前
斯文幻天发布了新的文献求助10
6秒前
Ting330发布了新的文献求助30
6秒前
魔域发布了新的文献求助10
6秒前
233发布了新的文献求助10
7秒前
深情安青的应助被luhuiluhui采纳,获得10
7秒前
NexusExplorer的应助被甜甜采纳,获得10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162505
求助须知:如何正确求助?哪些是违规求助? 9556847
关于积分的说明 21737152
捐赠科研通 7752926
什么是DOI,文献DOI怎么找? 3427801
关于科研通互助平台的介绍 2552714
邀请新用户注册赠送积分活动 2472405